机译:小细胞肺癌化疗患者循环肿瘤细胞和血清细胞死亡生物标志物的评价
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester;
the Christie Foundation Trust,Manchester;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester;
and the School of Cancer and Imaging Sciences,University of Manchester, Manchester, United Kingdom;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester|the Christie Foundation Trust,Manchester|and the School of Cancer and Imaging Sciences,University of Manchester, Manchester, United Kingdom;
the Christie Foundation Trust,Manchester|and the School of Cancer and Imaging Sciences,University of Manchester, Manchester, United Kingdom;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester|and the School of Cancer and Imaging Sciences,University of Manchester, Manchester, United Kingdom;
From the Clinical and Experimental Pharmacology Group,Paterson Institute for Cancer Research, University of Manchester, Manchester|the Christie Foundation Trust,Manchester|and the School of Cancer and Imaging Sciences,University of Manchester, Manchester, United Kingdom;
机译:小细胞肺癌化疗患者循环肿瘤细胞和血清细胞死亡生物标志物的评估。
机译:致编辑的信:“循环无细胞DNA和循环肿瘤细胞是一线化疗治疗的晚期非小细胞肺癌患者的预后和预测生物标志物”
机译:一线化疗治疗晚期非小细胞肺癌患者的循环无细胞DNA和循环肿瘤细胞作为预后和预测生物标志物。
机译:使用有效的体内技术(Gilupi Cellcollector
机译:循环肿瘤细胞作为肺癌的生物标志物
机译:小细胞肺癌化疗患者循环肿瘤细胞和血清细胞死亡生物标志物的评价
机译:小细胞肺癌化疗患者循环肿瘤细胞和血清细胞死亡生物标志物的评价